UK markets open in 18 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,188.05 +425.02 (+2.39%) CRUDE OIL
79.55 +0.55 (+0.70%) GOLD FUTURES
2,327.10 +16.10 (+0.70%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
45,897.93 -1,760.97 (-3.69%)
Sino Biopharmaceutical Limited (1177.HK)
HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
As of 02:27PM HKT. Market open.
Currency in HKD
Valuation measures4
| Market cap (intra-day) | 50.74B |
| Enterprise value | 49.07B |
| Trailing P/E | 24.48 |
| Forward P/E | 19.12 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.77 |
| Price/book (mrq) | 1.54 |
| Enterprise value/revenue | 1.87 |
| Enterprise value/EBITDA | 7.03 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.52 |
| 52-week change 3 | -37.35% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 4.360 |
| 52-week low 3 | 2.290 |
| 50-day moving average 3 | 2.942 |
| 200-day moving average 3 | 3.105 |
Share statistics
| Avg vol (3-month) 3 | 53.34M |
| Avg vol (10-day) 3 | 79.85M |
| Shares outstanding 5 | 18.79B |
| Implied shares outstanding 6 | 19.56B |
| Float 8 | 9.28B |
| % held by insiders 1 | 48.19% |
| % held by institutions 1 | 15.58% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.05 |
| Forward annual dividend yield 4 | 1.85% |
| Trailing annual dividend rate 3 | 0.05 |
| Trailing annual dividend yield 3 | 1.67% |
| 5-year average dividend yield 4 | 1.44 |
| Payout ratio 4 | 72.63% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 11 Jun 2024 |
| Last split factor 2 | 3:2 |
| Last split date 3 | 20 Jul 2020 |
Financial highlights
Currency in CNY.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 8.90% |
| Operating margin (ttm) | 20.76% |
Management effectiveness
| Return on assets (ttm) | 5.33% |
| Return on equity (ttm) | 12.12% |
Income statement
| Revenue (ttm) | 26.2B |
| Revenue per share (ttm) | 1.41 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | 6.38B |
| Net income avi to common (ttm) | 1.85B |
| Diluted EPS (ttm) | 0.110 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 14.12B |
| Total cash per share (mrq) | 0.77 |
| Total debt (mrq) | 12.72B |
| Total debt/equity (mrq) | 33.31% |
| Current ratio (mrq) | 1.05 |
| Book value per share (mrq) | 1.66 |
Cash flow statement
| Operating cash flow (ttm) | 6.07B |
| Levered free cash flow (ttm) | 3.01B |
© 2024 Yahoo. All rights reserved.